"At Retina Institute & Acuity Eye Group, our industry-leading team of optometrists, ophthalmologists, and retina doctors are committed to providing best-in-class patient care and comprehensive services to patients throughout Arcadia, Monrovia, Sierra Madre, and surrounding communities.Our eye care specialists are experts in the treatment of a number of diseases including retina disease, cataracts, and glaucoma. We also offer a robust optical center with a range of frames to choose from to fit all budgets, so you can leave seeing and feeling your best."

During the past decade, Retina Institute of California conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Institute of California" #1 sponsor was "Pfizer" with 2 trials, followed by "Aerpio Therapeutics" with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Companion Dx Reference Lab, LLC" with 1 trials sponsored and "Kubota Vision Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Retina Institute of California" are "Age-Related Maculopathy" (1 trials), "Choroidal Neovascularization" (1 trials), "Diabetic Macular Edema" (1 trials), "Diabetic Retinopathy" (1 trials) and "Genetics of Drug Metabolism" (1 trials). Many other conditions were trialed in "Retina Institute of California" in a lesser frequency.

Most popular intervention types in "Retina Institute of California" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ranibizumab" (2 trials), "AKB-9778" (1 trials), "Abicipar Pegol" (1 trials) and "Masked Sham Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Institute of California" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Retina Institute of California". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Retina Institute of California, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Institute of California, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".